Ebrantil and High blood cholesterol - a phase IV clinical study of FDA data

Summary:

High blood cholesterol is reported as a side effect among people who take Ebrantil (urapidil), especially for people who are female, 60+ old, also take Diovan, and have High blood pressure.

The phase IV clinical study analyzes which people have High blood cholesterol when taking Ebrantil. It is created by eHealthMe based on reports of 1,650 people who have side effects when taking Ebrantil from the FDA, and is updated regularly.

What is Ebrantil?

Ebrantil has active ingredients of urapidil. eHealthMe is studying from 1,656 Ebrantil users. Check the latest studies of Ebrantil.

What is High blood cholesterol?

High blood cholesterol is found to be associated with 2,277 drugs and 3,557 conditions by eHealthMe. Check the latest studies of High blood cholesterol.

On Jul, 16, 2026

1,650 people reported to have side effects when taking Ebrantil.
Among them, 12 people (0.73%) have High blood cholesterol.

Could Ebrantil cause High blood cholesterol?

Among these 12 people:

What is the gender of people who have High blood cholesterol when taking Ebrantil? *

female: 75 %
male: 25 %

What is the age of people who have High blood cholesterol when taking Ebrantil? *

What are other drugs people take besides Ebrantil? *

What are other side effects people have besides High blood cholesterol? *

High Blood Pressure: 5 people, 41.67%
Constipation: 5 people, 41.67%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 33.33%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 4 people, 33.33%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 4 people, 33.33%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 4 people, 33.33%
Diarrhea: 4 people, 33.33%
Rashes (redness): 4 people, 33.33%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 33.33%
Skin Erosion (a discontinuity of the skin): 4 people, 33.33%

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 58.33%
Constipation: 5 people, 41.67%
Visual Field Defect: 4 people, 33.33%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 33.33%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 4 people, 33.33%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 33.33%
Diarrhea: 4 people, 33.33%
Gastritis (inflammation of stomach): 4 people, 33.33%
Iron Deficiency Anaemia: 4 people, 33.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ebrantil and have High blood cholesterol?

- Check whether High blood cholesterol is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ebrantil:

Ebrantil (1,656 reports)

Browse all side effects of Ebrantil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with High blood cholesterol:

High blood cholesterol (2,277 drugs)

Browse all the conditions that are associated with High blood cholesterol:

High blood cholesterol (3,557 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on urapidil (the active ingredients of Ebrantil) and Ebrantil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.